"10.1371_journal.ppat.0020110","plos pathogens","2006-10-27T00:00:00Z","Marina Aspholm; Farzad O Olfat; Jenny Nordén; Berit Sondén; Carina Lundberg; Rolf Sjöström; Siiri Altraja; Stefan Odenbreit; Rainer Haas; Torkel Wadström; Lars Engstrand; Cristina Semino-Mora; Hui Liu; André Dubois; Susann Teneberg; Anna Arnqvist; Thomas Borén","Department of Odontology, Section of Oral Microbiology, Umeå University, Umeå, Sweden; Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden; The Swedish Institute for Infectious Disease Control, Solna, Sweden; Department of Molecular Biology, Umeå University, Umeå, Sweden; Institute of Molecular and Cell Biology, Tartu University, Tartu, Estonia; Max-von-Pettenkofer-Institute of Hygiene and Medical Microbiology, Department of Bacteriology, Munich, Germany,; Department of Infectious Diseases and Medical Microbiology, Lund University, Lund, Sweden; Laboratory of Gastrointestinal and Liver Studies, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America; Institute of Biomedicine, Department of Medical Biochemistry and Cell Biology, Göteborg University, Göteborg, Sweden","MA, FOO, JN, BS, CL, RS, SA, SO, CSM, HL, AD, ST, and AA conceived, designed and performed the experiments. MA, FOO, JN, BS, RS, AD, ST, and TB analyzed the data. SO, RH, AD, ST, and TB contributed reagents/materials/analysis tools. MA, AD, and TB wrote the paper with the assistance of RH, TW, LE, ST, and AA.","In 2002 TB filed a patent application for the use of SabA as a vaccine candidate, International PCT pending number PCT/SE02/00301/ Helicobacter pylori sialic acid binding adhesin, SabA, and sabA gene.","2006","10","Marina Aspholm","MA",17,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
